{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T04:24:13Z","timestamp":1775535853820,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":3030,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.bbadis.2005.02.001","type":"journal-article","created":{"date-parts":[[2005,2,25]],"date-time":"2005-02-25T17:53:21Z","timestamp":1109354001000},"page":"74-78","source":"Crossref","is-referenced-by-count":17,"title":["Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis"],"prefix":"10.1016","volume":"1740","author":[{"given":"Christopher","family":"Esapa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer H.","family":"Moffitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Novials","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan C.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marku","family":"Laakso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Gomis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2005.02.001_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(87)90825-7","article-title":"Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes","volume":"2","author":"Clark","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2005.02.001_bib2","first-page":"47","article-title":"Amyloid and polypeptide hormones: what is their interrelationship?","volume":"1","author":"Westermark","year":"1994","journal-title":"Int. J. Exp. Clin. Invest."},{"key":"10.1016\/j.bbadis.2005.02.001_bib3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1055\/s-2008-1070828","article-title":"Das amyloid der langerhansschen inseln und seine beziehung zum diabetes mellitus","volume":"105","author":"Schneider","year":"1980","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.bbadis.2005.02.001_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF00402271","article-title":"Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population","volume":"36","author":"de Koning","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2005.02.001_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0021-9975(86)90031-9","article-title":"Immuno-histochemical morphometry of pancreatic endocrine cells in diabetic normoglycaemic glucose-intolerant and normal cats","volume":"96","author":"O'Brien","year":"1986","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.bbadis.2005.02.001_bib6","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.2337\/diabetes.50.11.2514","article-title":"Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells","volume":"50","author":"Wang","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2005.02.001_bib7","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1128\/MCB.12.4.1777","article-title":"The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes","volume":"12","author":"German","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2005.02.001_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00125-003-1304-4","article-title":"Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?","volume":"47","author":"Clark","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2005.02.001_bib9","first-page":"1064","article-title":"A novel mutation in islet amyloid polypeptide (IAPP) gene promoter is associated with Type II diabetes mellitus","volume":"44","author":"Novials","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2005.02.001_bib10","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00125-004-1439-y","article-title":"Mutation at position \u2212132 in the islet amyloid polypeptide (IAPP) gene promoter enhances basal transcriptional activity through a new CRE-like binding site","volume":"47","author":"Novials","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2005.02.001_bib11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00125-003-1068-x","article-title":"Amylin gene promoter mutations predispose to Type 2 diabetes in New Zealand Maori","volume":"46","author":"Poa","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2005.02.001_bib12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1464-5491.2003.00951.x","article-title":"Studies of variability in the islet amyloid polypeptide gene in relation to type 2 diabetes","volume":"20","author":"Pildal","year":"2003","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bbadis.2005.02.001_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00125-002-0779-8","article-title":"Human calcium\/calmodulin-dependent protein kinase II gamma gene (CAMK2G): cloning, genomic structure and detection of variants in subjects with type II diabetes","volume":"45","author":"Gloyn","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2005.02.001_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0168-8227(00)00188-1","article-title":"Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance","volume":"50","author":"MacNamara","year":"2000","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbadis.2005.02.001_bib15","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/clinchem\/42.4.576","article-title":"Development of sensitive immunoassays to detect amylin and amylin-like peptides in unextracted plasma","volume":"42","author":"Percy","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbadis.2005.02.001_bib16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2337\/diabetes.47.4.640","article-title":"Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans","volume":"47","author":"Kahn","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2005.02.001_bib17","doi-asserted-by":"crossref","first-page":"11986","DOI":"10.1074\/jbc.272.18.11986","article-title":"Identification of cis- and trans-active factors regulating human islet amyloid polypeptide gene expression in pancreatic beta-cells","volume":"272","author":"Carty","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2005.02.001_bib18","doi-asserted-by":"crossref","first-page":"15330","DOI":"10.1074\/jbc.M908045199","article-title":"Glucose regulates islet amyloid polypeptide gene transcription in a PDX1- and calcium-dependent manner","volume":"275","author":"Macfarlane","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2005.02.001_bib19","first-page":"A334","article-title":"Could a mutation in the amylin gene promoter region explain hyperamylinemia in individuals predisposed to NIDDM?","volume":"41","author":"Lehto","year":"1992","journal-title":"Diabetes"},{"issue":"77","key":"10.1016\/j.bbadis.2005.02.001_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/03009734000000014","article-title":"Quantitative studies on amyloid in the islets of Langerhans","author":"Westermark","year":"1972","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.bbadis.2005.02.001_bib21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0046-8177(81)80197-9","article-title":"The relation of islet amyloid to the clinical type of diabetes","volume":"12","author":"Maloy","year":"1981","journal-title":"Human Pathol."},{"key":"10.1016\/j.bbadis.2005.02.001_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF00290389","article-title":"Non-uniform distribution of islet amyloid in the pancreas of \u2018maturity-onset\u2019 diabetic patients","volume":"27","author":"Clark","year":"1984","journal-title":"Diabetologia"},{"issue":"40","key":"10.1016\/j.bbadis.2005.02.001_bib23","first-page":"1113","article-title":"The S20G islet-associated polypeptide gene mutation in familial NIDDM","author":"Birch","year":"1997","journal-title":"Diabetologia"},{"issue":"45","key":"10.1016\/j.bbadis.2005.02.001_bib24","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2337\/diab.45.9.1279","article-title":"Missense mutation of amylin gene (S20G) in Japanese NIDDM patients","author":"Sakagashira","year":"1996","journal-title":"Diabetes"},{"issue":"44","key":"10.1016\/j.bbadis.2005.02.001_bib25","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s001250100531","article-title":"S20G mutation of the amylin gene is associated with Type II diabetes in Japanese. Study group of comprehensive analysis of genetic factors in diabetes mellitus","author":"Seino","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2005.02.001_bib26","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0002-9440(10)64848-1","article-title":"S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin","volume":"157","author":"Sakagashira","year":"2000","journal-title":"Am. J. Pathol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443905000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443905000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T23:33:31Z","timestamp":1586129611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443905000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0925443905000104"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2005.02.001","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}